Serum S100B, NSE, and GRIA1 levels as neurological biomarkers in lead exposure

Firat Oguz E., YILMAZ F. M. , Tutkun E., Yilmaz O. H. , Ercan M., Sezer S.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.48, no.3, pp.449-454, 2018 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.3906/sag-1511-174
  • Title of Journal : TURKISH JOURNAL OF MEDICAL SCIENCES
  • Page Numbers: pp.449-454

Abstract

Background/aim: The central nervous system is one of the major targets in lead exposure. Biomarkers for the diagnosis and follow-up of lead exposure have not been identified. In this study, serum S100B, neuron-specific enolase (NSE), and glutamate receptor 1 (GRIA1) levels were determined as possible biomarkers for lead neurotoxicity.